Abstract
Current research proves that immune dysregulation is a common feature of coronavirus disease 2019 (COVID-19), and immune exhaustion is associated with increased disease mortality. Immune checkpoint molecules, including the programmed cell death-1 (PD-1)/PD-1 ligand (PD-L1) axis, may serve as markers of disease severity. Accordingly, in this study, we evaluated the expression of PD-1/PD-L1 in patients with COVID-19. Blood immunophenotypes of hospitalized patients with moderate (n = 17, requiring oxygen support) and severe (n = 35, requiring mechanical ventilation in the intensive care setting) COVID-19 were compared and associated with clinical, laboratory, and survival data. The associations between severity and lymphocyte profiles were analysed at baseline and after 7 and 14 days of in-hospital treatment. Forty patients without COVID-19 infection were used as controls. For PD-1-positive T and B lymphocyte subsets, notable increases were observed between controls and patients with moderate or severe COVID-19 for CD4+PD-1+ T cells, CD8+PD-1+ T and CD19+PD-1+ B cells. Similar trends were observed for PD-L1-positive lymphocytes, namely, CD4+PD-L1+ T cells, CD8+PD-L1+ T cells and CD19+PD-L1+ B cells. Importantly, all markers associated with PD-1 and PD-L1 were stable over time for the analysed time points in the moderate and severe COVID-19 groups. Increased abundances of PD-1+ and PD-L1+ lymphocytes were associated with disease severity and mortality and were stable over time in patients with moderate to severe COVID-19. These immune exhaustion parameters may be attractive biomarkers of COVID-19 severity.
Keywords: disease severity; immunophenotype; lymphocyte; programmed cell death protein 1; severe acute respiratory syndrome coronavirus 2.
【저자키워드】 severe acute respiratory syndrome coronavirus 2, disease severity, lymphocyte, immunophenotype, programmed cell death protein 1, 【초록키워드】 COVID-19, Treatment, coronavirus disease, Coronavirus disease 2019, coronavirus, Biomarker, Lymphocytes, Mortality, intensive care, severe COVID-19, mechanical ventilation, T cells, severity, disease severity, Infection, B cells, COVID-19 severity, oxygen, hospitalized patients, severe acute respiratory syndrome Coronavirus, immune, Laboratory, PD-1, PD-L1, Protein, lymphocyte, T cell, survival, COVID-19 infection, immunophenotype, Research, Control, respiratory, disease, expression, moderate, B lymphocyte, association, marker, Ligand, immune dysregulation, CD19, dysregulation, moderate to severe, In-hospital, programmed cell death, acute respiratory syndrome, disease mortality, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, profile, programmed cell death protein, oxygen support, parameter, controls, Cell, current, evaluated, analysed, increase, were used, hospitalized patient, groups, notable, Increased, baseline, patients with COVID-19, patients with moderate, patients without COVID-19,